Clinical data for cancers of the cervix and head and neck relate oxygen levels in the tumour to treatment outcome.
Combining data for cancers of the cervix, uterine body and ovary, the age adjusted RR for women ever using OCs compared with those never doing so was 0.7 (95%CI, 0.5 0.8).
An independent carcinoma of the cervix data set with histology data was not available publically.
Data suggests that HPV infection of the cervix might influence HIV pathogenesis by inducing both immune and inflammatory related protein production that enhances HIV expression [ 11].
These data suggest that, in carcinoma of the cervix treated with radiotherapy, pretreatment measurements of CA125, but not SCC and TPA, may have a role to play in defining prognosis.
These data indicate that, in carcinoma of the cervix treated with radiotherapy, pretreatment tumour intrinsic radiosensitivity is an important prognostic parameter and contributes to prognosis independently of other established and putative parameters.
Unsupervised hierarchical clustering of the resultant data completely separated the cervix tumours into the two histological types.
At the time of treatment, the following data were collected: conformation and size of the cervix; transformation zone (TZ) type; size, grade, and number of the lesion(s) and their relation with endocervical canal and vagina; treatment modality; histology of the excised lesion (including margin section status), and patient's age.
To determine if hypoxia-related molecular markers were associated with Cu-ATSM retention, the PET imaging data of 15 patients with cancer of the cervix were compared with the expression of tissue molecular markers, which included VEGF, cyclo-oxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), carbonic anhydrase IX (CA-9) and apoptotic index.
Except for a trend towards shorter overall survival with MCT4 positive adenosquamous carcinomas of the cervix, no correlations with clinicopathological data have been found before.
